BlackRock Investment Management’s Pacific Biosciences PACB Stock Holding History

BlackRock Investment Management’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.55M	Sell	409,177 -2,095	-0.5%	-$15.2K	﹤0.01%	2392
2016 Q3	$3.69M	Buy	411,272 +15,232	+4%	+$127K	﹤0.01%	1704
2016 Q2	$2.79M	Buy	396,040 +45,768	+13%	+$418K	﹤0.01%	1861
2016 Q1	$2.98M	Buy	350,272 +27,353	+8%	+$269K	﹤0.01%	1731
2015 Q4	$4.24M	Sell	322,919 -12,513	-4%	-$112K	0.01%	1503
2015 Q3	$1.23M	Sell	335,432 -65,099	-16%	-$318K	﹤0.01%	2451
2015 Q2	$2.31M	Buy	400,531 +27,202	+7%	+$157K	﹤0.01%	2111
2015 Q1	$2.18M	Buy	373,329 +13,803	+4%	+$95.2K	﹤0.01%	1955
2014 Q4	$2.82M	Buy	359,526 +191,521	+114%	+$1.23M	﹤0.01%	1774
2014 Q3	$825K	Buy	168,005 +2,603	+2%	+$13.6K	﹤0.01%	2652
2014 Q2	$1.02M	Sell	165,402 -8,841	-5%	-$44.2K	﹤0.01%	2590
2014 Q1	$932K	Buy	174,243 +11,486	+7%	+$72.6K	﹤0.01%	2554
2013 Q4	$851K	Sell	162,757 -2,403	-1%	-$11K	﹤0.01%	2610
2013 Q3	$912K	Buy	165,160 +9,442	+6%	+$32.8K	﹤0.01%	2509
2013 Q2	$394K	Buy	+155,718	New	+$388K	﹤0.01%	2970

Other funds holding PACB

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

BlackRock Investment Management's PACB Position: Q4 2016 in Review

BlackRock Investment Management reduced its Pacific Biosciences (PACB) stake by 0.51% in Q4 2016, selling an estimated $15.2K and leaving 409,177 shares worth $1.55M. The position accounts for ﹤0.01% of the portfolio, ranked #2392.

BlackRock Investment Management first reported a position in PACB in Q2 2013 and has held it in 15 quarters since. The position peaked at $4.24M in Q4 2015. 115 funds tracked by Wall St. Rank hold PACB as of Q4 2016.

BlackRock Investment Management held 409,177 shares of Pacific Biosciences worth $1.55M as of Q4 2016.
BlackRock Investment Management sold 2,095 Pacific Biosciences shares in Q4 2016, an estimated $15.2K.
Pacific Biosciences made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2392 holding.
BlackRock Investment Management first reported a position in Pacific Biosciences in Q2 2013 and has held it in 15 quarters since.
BlackRock Investment Management's Pacific Biosciences position peaked at $4.24M in Q4 2015.
115 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.